Cliff Asness's BEAM Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 13,204 shares of Beam Therapeutics Inc. (BEAM) worth $366,014, representing 0.00% of the portfolio. First purchased in 2020-Q4, this medium-term investment has been held for 16 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in BEAM, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2025, adding 25,421 shares. Largest reduction occurred in Q4 2021, reducing 15,304 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Beam Therapeutics (BEAM) Holding Value Over Time
Track share changes against reported price movement
Quarterly Beam Therapeutics (BEAM) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +1,978 | Add 17.62% | 13,204 | $27.72 |
| Q3 2025 | -14,195 | Reduce 55.84% | 11,226 | $24.27 |
| Q2 2025 | +25,421 | New Buy | 25,421 | $17.01 |
| Q4 2024 | -8,842 | Sold Out | 0 | $0.00 |
| Q3 2024 | -169 | Reduce 1.88% | 8,842 | $24.50 |
| Q2 2024 | +2,487 | Add 38.12% | 9,011 | $23.43 |
| Q1 2024 | +6,524 | New Buy | 6,524 | $33.04 |
| Q1 2023 | -9,599 | Sold Out | 0 | $0.00 |
| Q4 2022 | -42 | Reduce 0.44% | 9,599 | $39.11 |
| Q3 2022 | +9,641 | New Buy | 9,641 | $47.61 |
| Q1 2022 | -7,424 | Sold Out | 0 | $0.00 |
| Q4 2021 | -15,304 | Reduce 67.34% | 7,424 | $79.74 |
| Q3 2021 | +4,228 | Add 22.85% | 22,728 | $87.03 |
| Q2 2021 | +7,979 | Add 75.84% | 18,500 | $128.70 |
| Q1 2021 | +2,122 | Add 25.26% | 10,521 | $80.03 |
| Q4 2020 | +8,399 | New Buy | 8,399 | $81.68 |
Cliff Asness's Beam Therapeutics Investment FAQs
Cliff Asness first purchased Beam Therapeutics Inc. (BEAM) in Q4 2020, acquiring 8,399 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Beam Therapeutics Inc. (BEAM) for 16 quarters since Q4 2020.
Cliff Asness's largest addition to Beam Therapeutics Inc. (BEAM) was in Q2 2025, adding 25,421 shares worth $432,411.
According to the latest 13F filing for Q4 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 13,204 shares of Beam Therapeutics Inc. (BEAM), valued at approximately $366,014.
As of the Q4 2025 filing, Beam Therapeutics Inc. (BEAM) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Beam Therapeutics Inc. (BEAM) was 25,421 shares, as reported at the end of Q2 2025.